Form 8-K

0001193125-20-135015.txt : 20200506 0001193125-20-135015.hdr.sgml : 20200506 20200506170113 ACCESSION NUMBER: 0001193125-20-135015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200430 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCA Healthcare, Inc. CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 273865930 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11239 FILM NUMBER: 20853447 BUSINESS ADDRESS: STREET 1: ONE PARK PLZ CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6153449551 MAIL ADDRESS: STREET 1: ONE PARK PLAZA CITY: NASHVILLE STATE: TN ZIP: 37203 FORMER COMPANY: FORMER CONFORMED NAME: HCA Holdings, Inc. DATE OF NAME CHANGE: 20101126 FORMER COMPANY: FORMER CONFORMED NAME: HCA INC/TN DATE OF NAME CHANGE: 20010627 FORMER COMPANY: FORMER CONFORMED NAME: HCA THE HEALTHCARE CO DATE OF NAME CHANGE: 20010419 8-K 1 d923149d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 6, 2020 (April 30, 2020)

HCA HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-11239

27-3865930

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)


One Park Plaza, Nashville, Tennessee		37203
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (615) 344-9551

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $.01 par value per share

HCA

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Executive Officer Compensation Changes in Response to COVID-19 Pandemic

On April 30, 2020, the Compensation Committee of the Board of Directors of HCA Healthcare, Inc. (the “Company”) approved an extension through June 30, 2020 of the previously announced 30 percent reduction in base salary for the Company’s named executive officers and other executive officers.

2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates

The Board of Directors of the Company previously approved, subject to stockholder approval, the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (the “2020 Stock Incentive Plan”). According to the results from the Company’s Annual Meeting of Stockholders held on May 1, 2020 (as noted in Item 5.07 below), the Company’s stockholders approved the 2020 Stock Incentive Plan. A detailed summary of the material terms of the 2020 Stock Incentive Plan appears on pages 33 – 50 of the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on March 20, 2020 (the “Proxy Statement”), and is incorporated herein by reference. That summary and the foregoing description of the 2020 Stock Incentive Plan do not purport to be complete and are qualified in their entirety by reference to the full text of the 2020 Stock Incentive Plan, a copy of which is attached to this report as Exhibit 10.1 and is incorporated herein by reference.

Item 5.03.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On May 4, 2020, the Company filed with the Delaware Secretary of State an amendment to the Company’s Amended and Restated Certificate of Incorporation, to be effective May 5, 2020, providing for the right to call special meetings of stockholders upon written request by holders of record of at least fifteen percent (15%) of the voting power of all outstanding shares of the Company’s common stock entitled to vote at such meeting. The Company’s Board of Directors has also adopted an amendment to the Company’s Second Amended and Restated Bylaws providing for the ability of such stockholders to request special meetings of stockholders, subject to certain conditions set forth therein. Copies of the amendment to the Company’s Amended and Restated Certificate of Incorporation, as filed with the Delaware Secretary of State, and the amendment to the Company’s Second Amended and Restated Bylaws reflecting these changes are attached hereto as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporated herein by reference.

Item 5.07.

Submission of Matters to a Vote of Security Holders.

In order to support the health and well-being of the Company’s stockholders, employees and community due to the impact of the COVID-19 pandemic, the Company held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 1, 2020 in a virtual meeting format only, via webcast. At the Annual Meeting, a total of 311,900,869 shares of our common stock, out of a total of 338,468,818 shares of common stock outstanding and entitled to vote, were represented in person or by proxy. Voting results from the Annual Meeting were as follows:

1. The following nine director nominees were elected to the Company’s Board of Directors for a one-year term, or until such director’s respective successor is duly elected and qualified or such director’s earlier death, resignation or removal, as follows:


	For		Against		Abstentions		Broker Non-Votes
Thomas F. Frist III		289,371,483		2,481,653		128,037		19,919,696
Samuel N. Hazen		291,334,012		478,110		169,051		19,919,696
Meg G. Crofton		282,404,853		9,446,816		129,504		19,919,696
Robert J. Dennis		275,168,216		16,679,072		133,885		19,919,696
Nancy-Ann DeParle		290,401,636		1,413,025		166,512		19,919,696
William R. Frist		290,541,715		1,308,653		130,805		19,919,696
Charles O. Holliday, Jr.		281,567,990		10,242,832		170,351		19,919,696
Michael W. Michelson		291,537,386		273,756		170,031		19,919,696
Wayne J. Riley, M.D.		288,736,787		3,113,492		130,894		19,919,696

2. The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2020 was ratified as follows:


For		Against		Abstentions		Broker Non-Votes
	297,922,737		13,849,448		128,684		0

3. The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Proxy Statement was approved as follows:


For		Against		Abstentions		Broker Non-Votes
	265,846,118		25,940,578		194,477		19,919,696

4. The 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates was approved as follows:


For		Against		Abstentions		Broker Non-Votes
	278,167,425		13,641,006		172,742		19,919,696

5. The amendment to the Company’s amended and restated certificate of incorporation to allow certain stockholders to request special meetings of stockholders was approved as follows:


For		Against		Abstentions		Broker Non-Votes
	291,287,131		553,802		140,240		19,919,696

6. The stockholder proposal regarding stockholders’ ability to act by written consent as described in the Proxy Statement was not approved as follows:


For		Against		Abstentions		Broker Non-Votes
	56,450,547		235,227,185		303,441		19,919,696

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits:


Exhibit No.		Description

	3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation of HCA Healthcare, Inc., as filed with the Secretary of State of Delaware on May 4, 2020 with an effective date of May 5, 2020.

	3.2	Amendment to the Second Amended and Restated Bylaws of HCA Healthcare, Inc. effective May 5, 2020.

	10.1	2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 4.4 to the Company’s Registration Statement on Form S-8 (File No. 333-237967), and incorporated herein by reference).

	104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


HCA HEALTHCARE, INC.

By:		/s/ John M. Franck II
		John M. Franck II
		Vice President – Legal and Corporate Secretary

Date: May 6, 2020

EX-3.1 2 d923149dex31.htm EX-3.1 EX-3.1

Exhibit 3.1

CERTIFICATE OF AMENDMENT

TO THE

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

HCA HEALTHCARE, INC.

Pursuant to the provisions of Section 242 of the General Corporation Law of the State of Delaware, HCA Healthcare, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows:

A. The name of the Corporation is HCA Healthcare, Inc.

B. The Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by deleting the text of Article IX in its entirety and inserting the following in lieu thereof:

ARTICLE IX

SPECIAL MEETINGS OF STOCKHOLDERS; ADVANCE NOTICE; ACTION BY

WRITTEN CONSENT

Special meetings of stockholders of the Corporation may be called by the Board of Directors pursuant to a resolution adopted by the affirmative vote of the majority of the total number of directors then in office, by the Chairman of the Board or by the Chief Executive Officer of the Corporation and, subject to the provisions of the Bylaws of the Corporation, a special meeting of the stockholders of the Corporation shall be called by the Secretary of the Corporation upon written request of the holders of record of at least fifteen percent (15%) of the voting power of all outstanding shares of Common Stock entitled to vote at such meeting, such voting power to be calculated and determined in the manner specified, and with any limitations as may be set forth, in the Corporation’s Bylaws. Subject to the rights of the holders of any shares of Preferred Stock issued and outstanding at such time, special meetings of stockholders may not be called by any other person or persons. Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. Any action required or permitted to be taken at any annual or special meeting of the stockholders of the Corporation may be taken only upon the vote of the stockholders at an annual or special meeting duly called and may not be taken by written consent of the stockholders.

C. The foregoing amendment was duly adopted pursuant to Section 242 of the General Corporation Law of the State of Delaware.

D. This Amendment to the Amended and Restated Certificate of Incorporation shall be effective at 12:01 a.m. Eastern Time on May 5, 2020.

[Signature Page Follows]

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its name this 4^th day of May, 2020.


HCA HEALTHCARE, INC.

By:		/s/ John M. Franck II
Name:		John M. Franck II
Title:		Vice President – Legal and Corporate Secretary

EX-3.2 3 d923149dex32.htm EX-3.2 EX-3.2

Exhibit 3.2

AMENDMENT

TO THE

SECOND AMENDED AND RESTATED BYLAWS

HCA HEALTHCARE, INC.

A Delaware Corporation

1. The Second Amended and Restated Bylaws (the “Bylaws”) of HCA Healthcare, Inc., a Delaware corporation (the “Company”), are hereby amended by deleting Section 3 of Article II in its entirety and replacing that Section with the following:

SECTION 3. SPECIAL MEETINGS.

A. Special meetings of the stockholders may be called at any time by the Board of Directors pursuant to a resolution adopted by the affirmative vote of the majority of the total number of directors then in office, by the chairman of the Board of Directors, or by the chief executive officer, and, subject to the requirements of this Section 3 and such other sections of these Bylaws as are applicable, a special meeting of the stockholders shall be called by the secretary of the Corporation upon written request to the secretary of the Corporation (each such request, a “Special Meeting Request” and such meeting a “Stockholder Requested Special Meeting”) of the holders of record of at least fifteen percent (15%) of the voting power of all outstanding shares of common stock of the Corporation (the “Common Stock”) entitled to vote at such meeting, which shares are determined to be “owned” (as defined below) (the “Requisite Percentage”), who have held such shares continuously for at least one year (such period, the “One-Year Period”) as of both (1) the date (the “Request Date”) such Special Meeting Request is delivered to or mailed to and received by the secretary of the Corporation in accordance with this Section 3 and (2) the record date for determining the stockholders entitled to vote at the Stockholder Requested Special Meeting and must continue to own the Requisite Percentage through such Stockholder Requested Special Meeting date; and who have complied in full with the requirements set forth in these Bylaws. A special meeting of stockholders, including any Stockholder Requested Special Meeting, may be held at such date, time and place, if any, within or without the State of Delaware as may be designated by the Board of Directors; provided, however, that the date of any Stockholder Requested Special Meeting shall be no fewer than thirty (30) and no more than ninety (90) days from the date a Special Meeting Request(s) satisfying the requirements set forth in these Bylaws and representing the Requisite Percentage is received by the secretary of the Corporation (or, in the case of any litigation related to the validity of the Special Meeting Request(s), 90 days after the resolution of such litigation); provided, further, that the Board of Directors shall have the discretion to cancel any Stockholder Requested Special Meeting that has been called but not yet held for any of the reasons set forth in Section 3(D) below. Except in accordance with this Section 3, stockholders shall not be permitted to propose business to be brought before a special meeting of the stockholders.

For purposes of determining the Requisite Percentage, a stockholder shall be deemed to “own” only those shares of Common Stock as to which the stockholder(s) of record making the Special Meeting Request or beneficial owner(s), if any, on whose behalf the Special Meeting Request is being made (each such record owner and beneficial owner, a “Requesting Stockholder”) possesses both (a) the full voting and investment rights pertaining to the shares and (b) the full economic interest in (including the opportunity for profit from and risk of loss on) such shares; provided, that the number of shares

calculated in accordance with clauses (a) and (b) shall not include any shares (1) sold by such stockholder or any of its Affiliates in any transaction that has not been settled or closed, (2) borrowed by such stockholder or any of its Affiliates for any purposes or purchased by such stockholder or any of its Affiliates pursuant to an agreement to resell or (3) subject to any option, warrant, forward contract, swap, contract of sale, other derivative or similar agreement entered into by such stockholder or any of its Affiliates, whether any such instrument or agreement is to be settled with shares of Common Stock of the Corporation or with cash based on the notional amount or value of shares of outstanding Common Stock of the Corporation subject thereto, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of (A) reducing in any manner, to any extent or at any time in the future, such stockholder’s or its Affiliates’ full right to vote or direct the voting of any such shares, and/or (B) hedging, offsetting or altering to any degree any gain or loss realized or realizable arising from maintaining the full economic ownership of such shares by such stockholder or Affiliate. For purposes of this Section 3, a stockholder shall “own” shares held in the name of its bank, broker or other nominee or intermediary so long as the stockholder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares through the special meeting date. A stockholder’s ownership of shares shall be deemed to continue during any period in which the stockholder has delegated any voting power by means of a proxy, power of attorney or other instrument or arrangement which is revocable at any time by the stockholder. A stockholder’s ownership of shares shall be deemed to continue during any period in which the stockholder has loaned such shares, provided that the person has the power to recall such loaned shares on no more than five (5) business days’ notice and (x) will promptly recall such loaned shares upon having received notice of the Stockholder Requested Special Meeting and (y) will continue to hold such recalled shares through the date of the Stockholder Requested Special Meeting. The terms “owned,” “owning” and other variations of the word “own” shall have correlative meanings. Whether outstanding shares of Common Stock of the Corporation are “owned” for these purposes shall be determined by the Board of Directors or any committee thereof, which determination shall be conclusive and binding on the Corporation and its stockholders.

B. To be in proper form and valid, a Special Meeting Request must be signed by the holders of the Requisite Percentage (or their duly authorized agents), be delivered to or mailed to and received by the secretary of the Corporation at the Corporation’s principal executive offices by registered mail, return receipt requested or by nationally recognized private overnight courier service and shall (A) set forth a statement of the specific purpose or purposes of the meeting and the matters proposed to be acted on at such special meeting (including the text of any resolutions proposed for consideration and, if such business includes a proposal to amend the Bylaws, the language of the proposed amendment), (B) bear the date of signature of each stockholder (or duly authorized agent) signing the request, (C) include (w) the name and address, as they appear in the Corporation’s books, of each stockholder signing such request (or on whose behalf the request is signed), (x) the number of shares of Common Stock “owned” by such stockholder, (y) one or more written statements from the record holder of the shares (and from each intermediary through which the shares are or have been held during the One-Year Period) verifying that, as of a date within seven (7) calendar days prior to the Request Date, the Requesting Stockholder owns, and has owned continuously for the One-Year Period, the Requisite Percentage, and the Requesting Stockholder’s agreement to provide, within five (5) business days after the record date for the Stockholder Requested Special Meeting, written statements from the record holder and intermediaries verifying the Requesting Stockholder’s continuous ownership of the Requisite Percentage through the record date; and (z) a certification from the stockholder submitting the request that the stockholders signing the request in the aggregate satisfy the Requisite Percentage, (D) describe any material interest of each such stockholder in the specific

purpose or purposes of the meeting, (E) contain any other information that would be required to be provided by a stockholder seeking to nominate directors or bring an item of business before an annual meeting of stockholders pursuant to Section 11 of Article II of these Bylaws, (F) include an acknowledgment by each stockholder and any duly authorized agent that any reduction in shares of Common Stock “owned” by such stockholder as of the date of delivery of the Special Meeting Request and prior to the record date for the proposed Stockholder Requested Special Meeting shall constitute a revocation of such request to the extent of such reduction, (G) include an agreement by each stockholder and any duly authorized agent to continue to satisfy the Requisite Percentage through the date of the Stockholder Requested Special Meeting and to notify the Corporation promptly, in the event of any decrease in shares of Common Stock “owned” by such stockholder following the delivery of the Special Meeting Request, and (H) include an agreement by each stockholder and any duly authorized agent to update the information provided to the Corporation to ensure that it is true and correct as of the record date for notice of the Stockholder Requested Special Meeting, and as of fifteen (15) days prior to the Stockholder Requested Special Meeting or any adjournment or postponement thereof, and such update shall be delivered to the secretary of the Corporation at the Corporation’s principal executive offices by registered mail, return receipt requested or by nationally recognized private overnight courier service not later than five (5) days after the record date of the Stockholder Requested Special Meeting (in the case of the update required to be made as of the record date), and not later than ten (10) days prior to the date of the Stockholder Requested Special Meeting or, if practical, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the Stockholder Requested Special Meeting has been adjourned or postponed) (in the case of the update required to be made as of fifteen (15) days prior to the Stockholder Requested Special Meeting or any adjournment or postponement thereof). In addition, the stockholder and any duly authorized agent shall promptly provide any other information reasonably requested by the Corporation. For the avoidance of doubt, in the event that the Requesting Stockholder consists of a group of stockholders, the requirements and obligations applicable to an individual Requesting Stockholder that are set forth in these Bylaws, including the One-Year Period, shall apply to each member of such group individually; provided, however, that the Requisite Percentage shall apply to the continuous ownership of the eligible group in the aggregate.

C. In determining whether a special meeting of stockholders has been requested by the record holders of shares representing in the aggregate at least the Requisite Percentage who have held such shares continuously for the One-Year Period, multiple Special Meeting Requests delivered to the secretary of the Corporation will be considered together only if (i) each Special Meeting Request identifies substantially the same purpose or purposes of the special meeting and substantially the same matters proposed to be acted on at the special meeting, in each case as determined by the Board of Directors (which, if such purpose is the nominating of a person or persons for election to the Board of Directors, will mean that the exact same person or persons are nominated in each relevant Special Meeting Request), and (ii) such Special Meeting Requests have been dated and delivered to the secretary of the Corporation within sixty (60) days of the earliest dated Special Meeting Request. A stockholder may revoke a Special Meeting Request at any time by written revocation delivered to the secretary of the Corporation. If, following such revocation, there are unrevoked requests from stockholders representing in the aggregate less than the Requisite Percentage, the Board of Directors, in its discretion, may cancel the special meeting.

D. At any Stockholder Requested Special Meeting, the business transacted shall be limited to the purpose(s) stated in the Special Meeting Request; provided, however, that the Board of Directors shall have the authority in its discretion to submit additional matters to the stockholders and to cause other business to be transacted. Notwithstanding the foregoing provisions of this Section 3, a

Stockholder Requested Special Meeting shall not be held if (i) the Special Meeting Request does not comply with these Bylaws, (ii) the business specified in the Special Meeting Request is not a proper subject for stockholder action under applicable law, (iii) the Board of Directors has called or calls for an annual or special meeting of stockholders to be held within 90 days after the secretary of the Corporation receives the Special Meeting Request and the Board of Directors determines that the business of such meeting includes (among any other matters properly brought before the annual or special meeting) the business specified in the Special Meeting Request, (iv) the Special Meeting Request is received by the secretary of the Corporation during the period commencing 90 days prior to the anniversary date of the prior year’s annual meeting of stockholders and ending on the date of the final adjournment of the next annual meeting of stockholders, (v) an identical or substantially similar item (a “Similar Item”) was presented at any meeting of stockholders held within 90 days prior to receipt by the secretary of the Corporation of the Special Meeting Request (and, for purposes of this clause (v), the nomination, election or removal of directors shall be deemed a “Similar Item” with respect to all items of business involving the nomination, election or removal of directors, the changing of the size of the Board of Directors and the filling of vacancies and/or newly created directorships), or (vi) the Special Meeting Request was made in a manner that involved a violation of Regulation 14A under the Exchange Act (as hereinafter defined), or other applicable law.

E. Except to the extent previously determined by the Board of Directors in connection with a Special Meeting Request, the chairperson of the Stockholder Requested Special Meeting shall determine at such meeting whether any proposed business or other matter to be transacted by the stockholders has not been properly brought before the special meeting and, if he or she should so determine, the chairperson shall declare that such proposed business or other matter was not properly brought before the meeting and such business or other matter shall not be presented for stockholder action at the meeting. In addition, notwithstanding the foregoing provisions of this Section 3, unless otherwise required by law, if the Requesting Stockholder(s) (or a qualified representative of the stockholder) does not appear at the Stockholder Requested Special Meeting to present a nomination or other proposed business, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the Corporation.

2. This Amendment shall be effective as of May 5, 2020.

EX-101.SCH 4 hca-20200430.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 5 hca-20200430_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 6 hca-20200430_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d923149d8k.htm d923149dex31.htm d923149dex32.htm hca-20200430.xsd hca-20200430_lab.xml hca-20200430_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	Apr. 30, 2020
Cover [Abstract]
Amendment Flag	false
Entity Central Index Key	0000860730
Current Fiscal Year End Date	--12-31
Document Type	8-K
Document Period End Date	Apr. 30, 2020
Entity Registrant Name	HCA HEALTHCARE, INC.
Entity Incorporation State Country Code	DE
Entity File Number	001-11239
Entity Tax Identification Number	27-3865930
Entity Address, Address Line One	One Park Plaza
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37203
City Area Code	(615)
Local Phone Number	344-9551
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Security 12b Title	Common Stock, $.01 par value per share
Trading Symbol	HCA
Security Exchange Name	NYSE
Entity Emerging Growth Company	false

XML 12 d923149d8k_htm.xml IDEA: XBRL DOCUMENT 0000860730 2020-04-30 2020-04-30 false 0000860730 --12-31 8-K 2020-04-30 HCA HEALTHCARE, INC. DE 001-11239 27-3865930 One Park Plaza Nashville TN 37203 (615) 344-9551 false false false false Common Stock, $.01 par value per share HCA NYSE false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d923149d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d923149d8k.htm" ] }, "labelLink": { "local": [ "hca-20200430_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "hca-20200430_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "hca-20200430.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hca", "nsuri": "http://www.hcahealthcare.com/20200430", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d923149d8k.htm", "contextRef": "duration_2020-04-30_to_2020-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "d923149d8k.htm", "contextRef": "duration_2020-04-30_to_2020-04-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.hcahealthcare.com//20200430/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001193125-20-135015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-20-135015-xbrl.zip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end